[1]JournalofMedicinalChemistry,1994,vol.37,p.2697-2703
[2]Patent:WO2006/114676,2006,A2.Locationinpatent:Page/Pagecolumn7
[3]Patent:US2009/197907,2009,A1.Locationinpatent:Page/Pagecolumn2
[1]JournalofMedicinalChemistry,1994,vol.37,p.2697-2703
[1]Patent:CN106560471,2017,A.Locationinpatent:Paragraph0057;0063;0069;0075;0081;0087;0093;0096
[2]SyntheticCommunications,2008,vol.38,p.122-127
[1]JournalofMedicinalChemistry,1994,vol.37,p.2697-2703
[2]JournalofMedicinalChemistry,1994,vol.37,p.2697-2703
[1]JournalofMedicinalChemistry,1994,vol.37,p.2697-2703
[2]Patent:EP2824103,2015,A1
Title: Loratadine and analogues: discovery and preliminary structure-activity relationship of inhibitors of the amino acid transporter B(0)AT2.
Journal: Journal of medicinal chemistry 20141126
Title: Rupatadine 10 mg in the treatment of immediate mosquito-bite allergy.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV 20120701
Title: Histamine and H1-antihistamines: celebrating a century of progress.
Journal: The Journal of allergy and clinical immunology 20111201
Title: Rupatadine and levocetirizine in chronic idiopathic urticaria: a comparative study of efficacy and safety.
Journal: Journal of drugs in dermatology : JDD 20111201
Title: Fexofenadine-induced urticaria.
Journal: Annals of dermatology 20111201
Title: Efficacy of second-generation antihistamines in patients with allergic rhinitis and comorbid asthma.
Journal: The Journal of asthma : official journal of the Association for the Care of Asthma 20111101
Title: Fixed drug eruption against rupatadine fumarate.
Journal: The Journal of craniofacial surgery 20110901
Title: Rupatadine for the treatment of allergic rhinitis and urticaria.
Journal: Expert review of clinical immunology 20110101
Title: Rupatadine improves nasal symptoms, quality of life (ESPRINT-15) and severity in a subanalysis of a cohort of Spanish allergic rhinitis patients.
Journal: Journal of investigational allergology & clinical immunology 20110101
Title: Morning and evening efficacy evaluation of rupatadine (10 and 20 mg), compared with cetirizine 10 mg in perennial allergic rhinitis: a randomized, double-blind, placebo-controlled trial.
Journal: Journal of asthma and allergy 20110101
Title: In vitro anti-inflammatory and anti-coagulant effects of antibiotics towards Platelet Activating Factor and thrombin.
Journal: Journal of inflammation (London, England) 20110101
Title: H1-antihistamine up-dosing in chronic spontaneous urticaria: patients' perspective of effectiveness and side effects--a retrospective survey study.
Journal: PloS one 20110101
Title: Olopatadine hydrochloride and rupatadine fumarate in seasonal allergic rhinitis: A comparative study of efficacy and safety.
Journal: Journal of pharmacology & pharmacotherapeutics 20110101
Title: Consensus statement on the management of urticaria.
Journal: Indian journal of dermatology 20110101
Title: Effect of bilastine upon nasal obstruction.
Journal: Journal of investigational allergology & clinical immunology 20110101
Title: Efficacy and tolerability of rupatadine at four times the recommended dose against histamine- and platelet-activating factor-induced flare responses and ex vivo platelet aggregation in healthy males.
Journal: The British journal of dermatology 20101201
Title: Rupatadine and levocetirizine for seasonal allergic rhinitis: a comparative study of efficacy and safety.
Journal: Archives of otolaryngology--head & neck surgery 20100801
Title: Rupatadine does not potentiate the CNS depressant effects of lorazepam: randomized, double-blind, crossover, repeated dose, placebo-controlled study.
Journal: British journal of clinical pharmacology 20100601
Title: No cardiac effects of therapeutic and supratherapeutic doses of rupatadine: results from a 'thorough QT/QTc study' performed according to ICH guidelines.
Journal: British journal of clinical pharmacology 20100401
Title: Prediction and evaluation of protein farnesyltransferase inhibition by commercial drugs.
Journal: Journal of medicinal chemistry 20100325
Title: [Rupatadine, oral Rupatall].
Journal: Journal de pharmacie de Belgique 20100301
Title: Stereoselective synthesis of desloratadine derivatives as antagonist of histamine.
Journal: Bioorganic & medicinal chemistry 20100215
Title: Rupatadine inhibits proinflammatory mediator secretion from human mast cells triggered by different stimuli.
Journal: International archives of allergy and immunology 20100101
Title: Rupatadine and heart rhythm disturbances.
Journal: Clinical pharmacology and therapeutics 20100101
Title: Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20100101
Title: Rupatadine improves nasal symptoms, airflow and inflammation in patients with persistent allergic rhinitis: a pilot study.
Journal: Journal of biological regulators and homeostatic agents 20100101
Title: Structurally diverse metal coordination compounds, bearing imidodiphosphinate and diphosphinoamine ligands, as potential inhibitors of the platelet activating factor.
Journal: Bioinorganic chemistry and applications 20100101
Title: Paradoxical exacerbation of chronic urticaria by H1-antihistamines and montelukast.
Journal: European annals of allergy and clinical immunology 20091201
Title: Rupatadine: pharmacological profile and its use in the treatment of allergic rhinitis.
Journal: Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India 20091201
Title: Treatment of acquired cold urticaria with rupatadine.
Journal: Allergy 20090901
Title: The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo- controlled treatment with rupatadine 10 and 20 mg.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV 20090901
Title: Pharmacological profile, efficacy and safety of rupatadine in allergic rhinitis.
Journal: Primary care respiratory journal : journal of the General Practice Airways Group 20090601
Title: Unsuspected polymorphic metabolism of rupatadine via its primary metabolite, desloratadine.
Journal: Primary care respiratory journal : journal of the General Practice Airways Group 20090601
Title: Heart rhythm disturbances associated with rupatadine: a case series from the Spanish and Portuguese pharmacovigilance systems.
Journal: Clinical pharmacology and therapeutics 20090501
Title: Torsade de pointes associated with rupatadine.
Journal: Revista espanola de cardiologia 20090301
Title: Simultaneous determination of rupatadine and its metabolite desloratadine in human plasma by a sensitive LC-MS/MS method: application to the pharmacokinetic study in healthy Chinese volunteers.
Journal: Journal of pharmaceutical and biomedical analysis 20090220
Title: Successful treatment of chronic drug-resistant urticaria with alprazolam.
Journal: The Journal of allergy and clinical immunology 20090201
Title: Safety of rupatadine administered over a period of 1 year in the treatment of persistent allergic rhinitis: a multicentre, open-label study in Spain.
Journal: Drug safety 20090101
Title: Futura study: evaluation of efficacy and safety of rupatadine fumarate in the treatment of persistent allergic rhinitis.
Journal: Brazilian journal of otorhinolaryngology 20090101
Title: Reduction of nasal volume after allergen-induced rhinitis in patients treated with rupatadine: a randomized, cross-over, double-blind, placebo-controlled study.
Journal: Journal of investigational allergology & clinical immunology 20090101
Title: Ebastine in the light of CONGA recommendations for the development of third-generation antihistamines.
Journal: Journal of asthma and allergy 20090101
Title: Determination of rupatadine in pharmaceutical formulations by a validated stability-indicating MEKC method.
Journal: Journal of separation science 20080901
Title: Herbex-kid Inhibits Immediate Hypersensitivity Reactions in Mice and Rats.
Journal: Evidence-based complementary and alternative medicine : eCAM 20080901
Title: Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I study.
Journal: Clinical therapeutics 20080901
Title: High performance liquid chromatography-tandem mass spectrometric determination of rupatadine in human plasma and its pharmacokinetics.
Journal: Journal of pharmaceutical and biomedical analysis 20080805
Title: A 12-week placebo-controlled study of rupatadine 10 mg once daily compared with cetirizine 10 mg once daily, in the treatment of persistent allergic rhinitis.
Journal: Allergy 20080701
Title: [Torsades de pointes associated with rupatadine].
Journal: Revista espanola de cardiologia 20080301
Title: Antihistaminic effects of rupatadine and PKPD modelling.
Journal: European journal of drug metabolism and pharmacokinetics 20080101
Title: Lack of effects between rupatadine 10 mg and placebo on actual driving performance of healthy volunteers.
Journal: Human psychopharmacology 20070701
Title: Rupatadine in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled multicentre study.
Journal: Allergy 20070501
Title: Influence of food on the oral bioavailability of rupatadine tablets in healthy volunteers: a single-dose, randomized, open-label, two-way crossover study.
Journal: Clinical therapeutics 20070501
Title: [Protective effect of rupatadine against oleic acid-induced acute lung injury in rabbits].
Journal: Yao xue xue bao = Acta pharmaceutica Sinica 20070301
Title: Once-daily rupatadine improves the symptoms of chronic idiopathic urticaria: a randomised, double-blind, placebo-controlled study.
Journal: European journal of dermatology : EJD 20070101
Title: Characterization of the de novo biosynthetic enzyme of platelet activating factor, DDT-insensitive cholinephosphotransferase, of human mesangial cells.
Journal: Mediators of inflammation 20070101
Title: [Antihistamines in allergic rhinitis].
Journal: Otolaryngologia polska = The Polish otolaryngology 20070101
Title: The proarrhythmic antihistaminic drug terfenadine increases spontaneous calcium release in human atrial myocytes.
Journal: European journal of pharmacology 20061228
Title: New antihistamines: a critical view.
Journal: Jornal de pediatria 20061101
Title: Evaluation of the cognitive, psychomotor and pharmacokinetic profiles of rupatadine, hydroxyzine and cetirizine, in combination with alcohol, in healthy volunteers.
Journal: Human psychopharmacology 20060101
Title: Effects of rupatadine vs placebo on allergen-induced symptoms in patients exposed to aeroallergens in the Vienna Challenge Chamber.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20060101
Title: Rupatadine 10 mg and cetirizine 10 mg in seasonal allergic rhinitis: a randomised, double-blind parallel study.
Journal: Journal of investigational allergology & clinical immunology 20050101
Title: Rupatadine 10 mg and ebastine 10 mg in seasonal allergic rhinitis: a comparison study.
Journal: Allergy 20040701
Title: Role of histamine and platelet-activating factor in allergic rhinitis.
Journal: Journal of physiology and biochemistry 20040601
Title: A randomized, double-blind, parallel-group study, comparing the efficacy and safety of rupatadine (20 and 10 mg), a new PAF and H1 receptor-specific histamine antagonist, to loratadine 10 mg in the treatment of seasonal allergic rhinitis.
Journal: Journal of investigational allergology & clinical immunology 20040101
Title: Central and peripheral evaluation of rupatadine, a new antihistamine/platelet-activating factor antagonist, at different doses in healthy volunteers.
Journal: Neuropsychobiology 20040101
Title: Rupatadine: a new selective histamine H1 receptor and platelet-activating factor (PAF) antagonist. A review of pharmacological profile and clinical management of allergic rhinitis.
Journal: Drugs of today (Barcelona, Spain : 1998) 20030601
Title: Antihistamines in late-phase clinical development for allergic disease.
Journal: Expert opinion on investigational drugs 20020201